Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7789]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Deep molecular response to gilteritinib in CHRYSALIS trial
Dr Jessica Altman - Robert H. Lurie Comprehensive Cancer Center of Northwestern...
Deep molecular response to gilteritinib in CHRYSALIS trial ( Dr Jessica Altman - Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA )
23 Jun 2017
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed...
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
Improving outcomes for oestrogen receptor positive breast cancer
Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy
Improving outcomes for oestrogen receptor positive breast cancer ( Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy )
19 Jun 2017
European guidelines for breast cancer treatment
Dr Ciarán Nicholl - Research Centre Ispra, European Commission, Belgium
European guidelines for breast cancer treatment ( Dr Ciarán Nicholl - Research Centre Ispra, European Commission, Belgium )
19 Jun 2017
ESMO ranking of the clinical benefits of new drugs
Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy
ESMO ranking of the clinical benefits of new drugs ( Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy )
19 Jun 2017
The recent past and near future of drug approvals in Europe
Prof Filippo de Braud - Istituto Nazionale dei Tumori, Milan, Italy
The recent past and near future of drug approvals in Europe ( Prof Filippo de Braud - Istituto Nazionale dei Tumori, Milan, Italy )
19 Jun 2017
Aromatase gene amplification
Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy
Aromatase gene amplification ( Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy )
19 Jun 2017
Personalised medicine for rare cancers
Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy
Personalised medicine for rare cancers ( Prof Paolo Casali - Università degli Studi di Milano, Milan, Italy )
19 Jun 2017
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate...
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(5/6) ASCO 2017: ASCO highlights in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(5/6) ASCO 2017: ASCO highlights in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation